Results 181 to 190 of about 89,135 (337)

Neoadjuvant Under‐Dilated TIPS: Expanding Surgeries for Extrahepatic Malignancies in Patients With Cirrhosis and CSPH

Liver International, Volume 46, Issue 1, January 2026.
ABSTRACT Background & Aims Portal hypertension is a major challenge in patients with cirrhosis requiring surgery. This study aimed to evaluate the efficacy of under‐dilated neoadjuvant transjugular intrahepatic portosystemic shunt (U.N‐TIPS) in enabling elective extrahepatic oncologic surgery in patients with cirrhosis and clinically significant portal
Dario Saltini, Davide Roccarina, Marco Senzolo, Cristian Caporali, Fabrizio Fanelli, Marcello Bianchini, Federico Casari, Angelica Ingravallo, Silvia Aspite, Tomas Guasconi, Antonio Piscopo, Andrea Salome Velasco Mayorga, Barbara Catellani, Gian Piero Guerrini, Stefano Di Sandro, Fabio Staderini, Umberto Cillo, Fabrizio Di Benedetto, Antonio Colecchia, Fabio Marra, Patrizia Burra, Francesco Vizzutti, Filippo Schepis   +22 more
wiley   +1 more source

Rethinking the prognostic significance of bile spillage in gallbladder cancer. [PDF]

World J Gastrointest Surg
Liau MYQ, Shelat VG.
europepmc   +1 more source

Diagnosis of Gallbladder Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Profiling [PDF]

, 2011
Yonghua Mou, Renwei Xing, Chibo Liu
openalex   +1 more source

Cancer incidence, stage at diagnosis, and trends across the Navajo Nation, 2014–2018

Cancer, Volume 131, Issue 24, 15 December 2025.
Abstract Background American Indian/Alaska Native (AI/AN) people in the United States experience cancer disparities, but little is known about cancer patterns specific to each Tribal Nation. This study describes cancer incidence (2014–2018), trends (1998–2018), and stage of diagnosis across the Navajo Nation, one of the largest sovereign tribal nations
Del Yazzie, Dornell Pete, Curtis Briscoe, Melissa A. Jim, Angela Meisner, Charles Wiggins, Dana Doyle, Georgia Yee, Carol Goldtooth, Priscilla R. Sanderson, Chesleigh Nicole Keene, Melinda Smith, Hannah Sehn, Shawnell Damon, Chelsea L. Kettering, Marc Emerson, Caleigh Curley, Jennifer Bea, Sheldwin Yazzie, Natalie Joe, Jennifer Doherty, Hendrik Dirk de Heer, On behalf of the Navajo Cancer Workgroup   +22 more
wiley   +1 more source

Prognostic value of preoperative serum tumor markers in gallbladder cancer. [PDF]

BMC Gastroenterol
Duan Q, Zhong J, Song Y, Zhang S, Yi W, Peng C, Liu S, Wu J, Zou L.   +8 more
europepmc   +1 more source

Thirteen simple lifestyle scores and risk of cancer, cardiovascular disease, diabetes, and mortality: Prospective cohort study in the UK Biobank

International Journal of Cancer, Volume 157, Issue 12, Page 2495-2505, 15 December 2025.
What's New? Cancer, cardiovascular disease, and type 2 diabetes share common lifestyle‐related risk factors. This large‐scale prospective cohort study examined and compared the associations between 13 simple lifestyle scores and these major non‐communicable diseases.
Jie Ding, Ben Schöttker, Hermann Brenner, Michael Hoffmeister   +3 more
wiley   +1 more source

The Interplay Between CA19-9 and the Lewis Blood Group System: Implications for the Diagnosis of Gallbladder Cancer. [PDF]

Can J Gastroenterol Hepatol
Liu Y, Zhang J, Zheng Z, Zheng W, Fang L, Zhou F, Liang B.   +6 more
europepmc   +1 more source

Imeglimin attenuates liver fibrosis by inhibiting vesicular ATP release from hepatic stellate cells

FEBS Letters, Volume 599, Issue 23, Page 3524-3536, December 2025.
Imeglimin, at clinically relevant concentrations, inhibits vesicular ATP accumulation and release from hepatic stellate cells, thereby attenuating purinergic signaling and reducing fibrogenic activation. This mechanism reveals a newly identified antifibrotic action of imeglimin beyond glycemic control.
Seiji Nomura, Lixiang Wang, Nao Hasuzawa, Ayako Nagayama, Sawako Moriyama, Kenji Ashida, Yoshinori Moriyama, Masatoshi Nomura, Ken Yamamoto   +8 more
wiley   +1 more source

Individualized Prognostic Insights: CONUT-GBRS for Survival Prediction in Gallbladder Cancer. [PDF]

Cancer Med
Yang SQ, Zou RQ, Dai YS, Wang JK, Ma WJ, Hu HJ, Li FY.   +6 more
europepmc   +1 more source

miR‑433 accelerates acquired chemoresistance of gallbladder cancer cells by targeting cyclin M

, 2017
Jianhua Yu, Weiguang Zhang, Baochun Lu, Hongwei Qian, Haijun Tang, Zhiyang Zhu, Yuan Xing-gui, Peitu Ren   +7 more
openalex   +2 more sources